Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Marketsadaptogenics healthberkwood researchglp-1acquisition

Adaptogenics Health buys Berkwood Research assets for US$27,000

The small acquisition is tied to what the company calls a GLP-1 companion initiative.

TR
By Tom Reyes · Markets Editor
Oct 8 16:33 ETSource: kalkine.ca

The wire

  1. 01Adaptogenics Health Corp. said it acquired the assets of Berkwood Research for US$27,000 to launch a GLP-1 companion initiative.
  2. 02Companion products aimed at GLP-1 users are an emerging commercial niche operators and pharmacists are watching alongside incretin prescribing.
  3. 03No product, timeline or clinical data accompanied the announcement, and the purchase price is small; details rest on the company's own statement.

From the source

Adaptogenics Health Corp. Acquires Berkwood Research Assets for US$27,000 to Launch GLP-1 Companion Initiative

Read at kalkine.ca
PeptiPrescribed peptides from $99/moSee all →